Literature DB >> 23673440

Depressive symptoms and treatment of women with urgency urinary incontinence.

Rachel Kafri1, Arad Kodesh, Jeffrey Shames, Jacob Golomb, Itshak Melzer.   

Abstract

INTRODUCTION AND HYPOTHESIS: Depression is more common in patients with urinary incontinence (UI). Drug or rehabilitation therapy have been shown to be effective in reducing urgency UI (UUI) symptoms, but whether these treatments can ameliorate the negative impact of UUI on the psychological aspects of quality of life is unclear.
METHODS: A secondary analysis of an assessor-blinded randomized controlled trial was performed. The number of depressive symptoms was the primary outcome as measured by the Center for Epidemiologic Studies Depression scale (CES-D).
RESULTS: Thirty-six (22%) subjects had a CES-D score >16 at baseline, the cutoff for having depressive symptoms. A significant association was found between having a CES-D score >16 and lower quality of life related to UI at baseline. The mean CES-D score among those with depressive symptoms at baseline was significantly reduced throughout the study, with a mean of 23.7 at baseline, to 18.3 and 15.2 at the 3-month and 1-year follow-up (p < 0.001), respectively. The number of participants who had depressive symptoms decreased during the study period only in the physical therapy groups, from 31 at baseline to 28 and 25, at 3 and 12 months, respectively, while there was no such change in the drug group.
CONCLUSIONS: Patients with UUI who had depressive symptoms showed significant improvement in their depressive symptoms with treatment over 1 year. This improvement occurred regardless of the type of treatment. This study emphasizes the increasingly recognized problem of undiagnosed depression among middle-aged women with UUI.

Entities:  

Mesh:

Year:  2013        PMID: 23673440     DOI: 10.1007/s00192-013-2116-9

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  16 in total

Review 1.  Patient-reported outcomes and different approaches to urinary parameters in overactive bladder: what should we measure?

Authors:  Vik Khullar
Journal:  Int Urogynecol J       Date:  2011-10-20       Impact factor: 2.894

2.  Psychological improvements associated with behavioral and drug treatment of urge incontinence in older women.

Authors:  K L Burgio; J L Locher; D L Roth; P S Goode
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2001-01       Impact factor: 4.077

Review 3.  Depression and incontinence.

Authors:  W D Steers; K S Lee
Journal:  World J Urol       Date:  2001-11       Impact factor: 4.226

4.  Association between urinary incontinence and depressive symptoms in overweight and obese women.

Authors:  Vivian W Sung; Delia S West; Alexandra L Hernandez; Thomas L Wheeler; Deborah L Myers; Leslee L Subak
Journal:  Am J Obstet Gynecol       Date:  2009-02-23       Impact factor: 8.661

5.  Depression in primary care in Israel.

Authors:  Galit Geulayov; Joshua Lipsitz; Ron Sabar; Raz Gross
Journal:  Isr Med Assoc J       Date:  2007-08       Impact factor: 0.892

Review 6.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Authors:  Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer
Journal:  Int Urogynecol J       Date:  2009-11-25       Impact factor: 2.894

7.  Effect of biofeedback on psychological burden and symptoms in older women with urge urinary incontinence.

Authors:  Stasa D Tadic; Bozena Zdaniuk; Derek Griffiths; Lisa Rosenberg; Werner Schäfer; Neil M Resnick
Journal:  J Am Geriatr Soc       Date:  2007-11-20       Impact factor: 5.562

Review 8.  Physical activity, exercise, depression and anxiety disorders.

Authors:  Andreas Ströhle
Journal:  J Neural Transm (Vienna)       Date:  2008-08-23       Impact factor: 3.575

9.  The Israel National Health Survey: issues and methods.

Authors:  Daphna Levinson; Ari Paltiel; Michal Nir; Tzahi Makovki
Journal:  Isr J Psychiatry Relat Sci       Date:  2007       Impact factor: 0.481

10.  Improvement of quality of life, anxiety and depression after surgery in patients with stress urinary incontinence: results of a longitudinal short-term follow-up.

Authors:  Petra C Innerkofler; Verena Guenther; Peter Rehder; Martin Kopp; Dominic P Nguyen-Van-Tam; Johannes M Giesinger; Bernhard Holzner
Journal:  Health Qual Life Outcomes       Date:  2008-09-29       Impact factor: 3.186

View more
  5 in total

1.  Life Space Assessment in Older Women Undergoing Non-Surgical Treatment for Urinary Incontinence.

Authors:  Thomas L Wheeler; Jana D Illston; Alayne D Markland; Patricia S Goode; Holly E Richter
Journal:  Open J Obstet Gynecol       Date:  2014-10

2.  Effects on Depression and Anxiety After Mid-Urethral Sling Surgery for Female Stress Urinary Incontinence.

Authors:  Manami Kinjo; Kazuki Masuda; Yu Nakamura; Satoru Taguchi; Mitsuhiro Tambo; Takatsugu Okegawa; Hiroshi Fukuhara
Journal:  Res Rep Urol       Date:  2020-10-19

3.  Cost-effectiveness of a nurse-led intervention to optimise implementation of guideline-concordant continence care: Study protocol of the COCON study.

Authors:  Aaltje P D Jansen; Maaike E Muntinga; Judith E Bosmans; Bary Berghmans; Janny Dekker; Jacqueline Hugtenburgh; Giel Nijpels; Paul van Houten; Miranda G H Laurant; Huub C H van der Vaart
Journal:  BMC Nurs       Date:  2017-02-22

4.  Conceptualization and Inventory of the Sexual and Psychological Burden of Women With Pelvic Floor Complaints; A Mixed-Method Study.

Authors:  Alma M Brand; Scott Rosas; Wim Waterink; Slavi Stoyanov; Jacques J D M van Lankveld
Journal:  Sex Med       Date:  2022-03-23       Impact factor: 2.523

5.  Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms.

Authors:  Andrzej Wróbel; Anna Serefko; Ewa Poleszak; Tomasz Rechberger
Journal:  Int Urogynecol J       Date:  2016-05-03       Impact factor: 2.894

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.